Measles poses growing threat to kids as vaccinations decline globally, CDC and WHO warn

Measles poses growing threat to kids as vaccinations decline globally, CDC and WHO warn


A growing number of children around the world are vulnerable to measles as vaccination rates have declined to the lowest levels since 2008, global health leaders warned on Wednesday.

The Covid-19 pandemic badly disrupted routine vaccination services which resulted in millions of kids missing their measles shots, according to a report from the World Health Organization and the U.S. Centers for Disease Control and Prevention.

About 81% of children worldwide received the first dose of the measles vaccine in 2021, down from 86% in 2019 before the Covid pandemic began. This leaves 25 million kids vulnerable to measles, according the report.

Public health experts estimate 95% of children need to be vaccinated against measles to prevent outbreaks. The measles vaccine comes in two doses, but the first shot is the most important because it’s 93% effective at preventing disease.

Steady progress has been made toward eliminating measles over the past 20 years. Deaths from measles have dropped 83% globally from 761,000 in 2000 to 128,000 in 2021 as vaccine coverage has increased, according to the report.

But CDC Director Dr. Rochelle Walensky and WHO Chief Dr. Tedros Adhanom Ghebreyesus, in separate statements Wednesday, expressed concern that measles could stage a comeback as vaccination rates have been falling for two years now.

The U.S. officially eliminated measles more than 20 years but travelers sometimes bring the virus into the country. This can cause outbreaks if vaccination rates are too low in their communities, according to the CDC.

Measles is one of the most contagious diseases known to humans. It poses a serious health risk for children younger than age 5, adults older than age 20, pregnant women and people with compromised immune systems.

The virus spreads when an infected person coughs or sneezes and it can linger in the air for up to two hours. Measles is so contagious that a person who gets infected will pass it on to 90% of their close contacts who are not protected, according to the CDC.

One in five unvaccinated people who catch measles are hospitalized, according to the CDC. One in 20 unvaccinated kids who catch measles develop pneumonia, 3 in 1,000 develop brain swelling, and as many as 3 in every 1,000 will die from respiratory or neurological complications.

Symptoms start with a high fever that can spike to more than 104 degrees, a cough and a runny nose. White spots then appear inside the mouth and a rash of reds spots breaks out across the body.

The two-dose vaccine is 97% effective at preventing measles. The first dose is administered at age 1 year to 15 months, and the second dose is given between ages 4 and 6 years old.



Source

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
Health

Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers

The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients […]

Read More
Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula
Health

Laura Modi, CEO and mom, is breaking one of the market’s biggest duopolies: Infant formula

Laura Modi, co-founder and CEO of infant formula startup Bobbie, is on a mission to transform an industry that she says has been stagnant for decades, and shift the culture around how parents feed their babies. Modi, a former Airbnb executive, came up with the idea for Bobbie after the birth of her first child. […]

Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Health

Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers

U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]

Read More